Tech Company Financing Transactions

Igenica Funding Round

Third Rock Ventures, 5AM Ventures and OrbiMed participated in a $33 million Series C funding round for Igenica. This VC investment round was announced on 6/12/2012.

Transaction Overview

Company Name
Igenica
Announced On
6/12/2012
Transaction Type
Venture Equity
Amount
$33,000,000
Round
Series C
Investors

Third Rock Ventures (Lead Investor) (Mark Goldsmith)

5AM Ventures (John Diekman)

OrbiMed (Carl Gordon)

The Column Group (David Goeddel)

Proceeds Purpose
Proceeds from the financing will be used to advance the company's monoclonal antibody pipeline toward clinical trials. These funds will also be used to apply Igenica's unique discovery approach, consisting of the sTAg target discovery platform and the iTAb antibody discovery platform, toward the discovery of new monoclonal antibodies against a broad range of drug targets that have not been previously investigated for the treatment of cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
863 Mitten Rd. 102
Burlingame, CA 94010
USA
Phone
(650) 231-4320
Website
www.igenica.com
Email Address
[email protected]
Overview
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Profile
Igenica LinkedIn Company Profile
Social Media
Igenica Company Twitter Account
Company News
Igenica News
Facebook
Igenica on Facebook
YouTube
Igenica on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Hans van Houte
  Hans van Houte LinkedIn Profile  Hans van Houte Twitter Account  Hans van Houte News  Hans van Houte on Facebook
VP - Bus. Development
John Celebi
  John Celebi LinkedIn Profile  John Celebi Twitter Account  John Celebi News  John Celebi on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/11/2012: Blaze Bioscience venture capital transaction
Next: 6/12/2012: VeraLight venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.